News

Can Ozempic and other GLP-1 drugs be substitute for work outs? Dr Ambrish Mithal and Raj Ganpath discuss
Endocrinologist Dr Ambrish Mithal, the author of the recently-released book, The Weight Loss Revolution, talks to fitness and ...
Dr Ambrish Mithal decodes Ozempic and other GLP-1 drugs, with Raj Ganpath
Endocrinologist Dr Ambrish Mithal, the author of the recently-released book, The Weight Loss Revolution, talks to fitness and ...
Physician's Weekly1h
GLP-1 Receptor Agonist Use in T2D Tied to Increased Risk for GERD, GERD Complications
For patients with type 2 diabetes, glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are associated with an increased ...
Optometry Advisor18h
Certain Factors May Predict Weight Fluctuations After GLP-1 Receptor Agonist Treatment
For adults with overweight or obesity, certain factors might influence weight loss after taking glucagon-like peptide 1 receptor agonists (GLP-1 RAs).
The Cardiology Advisor18h
Adrenal Adenomas May Attenuate Weight Loss With Incretin-Based Therapy
Adrenal adenomas were associated with attenuated weight loss among patients with obesity or overweight using GLP-1 or GIP/GLP-1 RAs.